Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$821M |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$568M |
| 3 |
Advanced Micro Devices
AMD
|
+$428M |
| 4 |
XYZ
Block Inc
XYZ
|
+$419M |
| 5 |
VanEck Semiconductor ETF
SMH
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$683M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$488M |
| 3 |
Marvell Technology
MRVL
|
+$420M |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$375M |
| 5 |
PayPal
PYPL
|
+$326M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.02% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.27% |
| 4 | Consumer Discretionary | 8.74% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CADE
251
DELISTED
Cadence Bank
CADE
| $37.4M | 0.03% |
1,516,474
+166,544
| +12% | +$4.47M |
|
|
JWN
252
DELISTED
Nordstrom
JWN
| $37.3M | 0.03% |
2,312,992
+584,293
| +34% | +$11.2M |
|
253
Semtech
SMTC
$12.6B
| $37.2M | 0.03% |
1,297,628
-5,541
| -0.4% | -$157K |
|
|
BPMC
254
DELISTED
Blueprint Medicines
BPMC
| $36.9M | 0.03% |
843,090
+117,553
| +16% | +$5.64M |
|
255
Delek US
DK
$3.59B
| $36.9M | 0.02% |
1,365,469
-17,772
| -1% | -$525K |
|
256
Glacier Bancorp
GBCI
$6.32B
| $36.7M | 0.02% |
742,489
+88,134
| +13% | +$4.75M |
|
257
Biogen
BIIB
$30.5B
| $36.7M | 0.02% |
132,495
+2,034
| +2% | +$574K |
|
|
FRC
258
DELISTED
First Republic Bank
FRC
| $36.7M | 0.02% |
300,877
-5,404
| -2% | -$659K |
|
259
Range Resources
RRC
$9.01B
| $36.3M | 0.02% |
1,452,680
-592,065
| -29% | -$16.2M |
|
260
EOG Resources
EOG
$71.4B
| $36.2M | 0.02% |
279,309
+1,047
| +0.4% | +$139K |
|
261
Dana Inc
DAN
$2.94B
| $35.7M | 0.02% |
2,360,949
+911,344
| +63% | +$14.1M |
|
262
ScottsMiracle-Gro
SMG
$3.61B
| $35.6M | 0.02% |
733,378
-7,257
| -1% | -$363K |
|
263
WIX.com
WIX
$2.55B
| $35.5M | 0.02% |
462,028
-620
| -0.1% | -$50.1K |
|
264
Yelp
YELP
$1.38B
| $35M | 0.02% |
1,280,497
-1,592,968
| -55% | -$50.5M |
|
265
Warner Bros
WBD
$66.2B
| $34.1M | 0.02% |
3,597,426
+3,319,101
| +1,193% | +$37.5M |
|
266
A.O. Smith
AOS
$8.56B
| $32.9M | 0.02% |
575,581
+138,204
| +32% | +$7.73M |
|
267
Integra LifeSciences
IART
$1.33B
| $32.3M | 0.02% |
576,396
-184
| -0% | -$9.37K |
|
268
Nice
NICE
$5.69B
| $30.5M | 0.02% |
158,735
-25,339
| -14% | -$4.88M |
|
269
CONMED
CNMD
$1.49B
| $30.4M | 0.02% |
343,360
+42,227
| +14% | +$3.5M |
|
270
Bilibili
BILI
$7.81B
| $30.4M | 0.02% |
1,283,335
-58,191
| -4% | -$926K |
|
271
Aptiv
APTV
$9.61B
| $30.1M | 0.02% |
323,202
+250,923
| +347% | +$23.9M |
|
272
IDEX
IEX
$17.2B
| $30.1M | 0.02% |
131,821
+2,337
| +2% | +$522K |
|
273
Intel
INTC
$503B
| $30M | 0.02% |
1,133,979
-297,803
| -21% | -$8.27M |
|
274
LXP Industrial Trust
LXP
$3.57B
| $29.9M | 0.02% |
597,699
+488,499
| +447% | +$24.4M |
|
275
Medpace
MEDP
$16.3B
| $29.8M | 0.02% |
140,422
-164,163
| -54% | -$32.8M |
|
Similar funds
Ken Fisher's Q4 2022 Portfolio in Review
As of Q4 2022, Ken Fisher held 1,228 positions worth $148B, up 11% from $133B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q4 2022 filing shows 150 new, 438 increased, 394 reduced and 203 closed positions. Its largest new stake was Macerich: 4,023,537 shares worth $45.3M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $683M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2022 buy was Macerich: 4,023,537 shares worth $45.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2022, an estimated $821M increase.
- Ken Fisher's biggest Q4 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $683M.
- Ken Fisher fully exited Fair Isaac in Q4 2022, selling an estimated $35.3M.
- Ken Fisher's ten largest holdings make up 26% of its $148B portfolio in Q4 2022.
- Ken Fisher opened 150 new positions and closed 203 in Q4 2022.
- Ken Fisher's portfolio value rose 11% quarter-over-quarter to $148B.
Based on Fisher Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.